More than 20 years in the packaging industry. Eleven years in Huhtamaki managing global FMCG accounts.
He is very well experienced on existing and new paperboard packaging solutions while he is already working on upcoming new technologies for molded fiber solutions.
With long-standing experience in category management, product management, marketing, and sales. Salla is committed to foster collaboration and bring a positive, forward-looking perspective to every project and audience.
I am a Marketing Business Partner specialised in the food and dairy industry. With a strong background in business analysis and market research, I combine data-driven thinking with creative marketing execution. I translate business objectives into actionable marketing strategies that drive growth, brand positioning, and commercial performance.
I manage the communication and advertising for Sacco System within the Food Business Unit gloablly, ensuring all messaging aligns with our brand and business goals. I collaborate cross-functionally with sales and product management to ensure alignment and measurable impact. Passionate about innovation, I actively explore market trends, consumer insights, and new opportunities to create a competitive advantage.
I am responsible for the sales development and application of enzymes and dairy cultures from Sacco System within the Food Business Unit, with 35 years of hands-on experience in the field. My role focuses on driving business growth, supporting customers with technical expertise, and ensuring product performance across diverse markets.
My current area of responsibility covers Northern Europe, the Baltic countries, DACH, Central Europe, and the Balkans down to Greece. I manage distributor relationships and maintain direct contacts with key accounts (KA) and local key accounts (LKA), ensuring alignment between market needs and our solutions. Combining deep technical knowledge with strategic sales management, I strengthen market presence and create sustainable business opportunities.
Roy supports customers with formulation and pilot-scale validation in dairy and cheese systems. His work focuses on building robust structure and texture that survives processing, transport, and shelf life.
Meleknur specializes in translating technical dairy capabilities into commercial clarity. By bridging market analysis and product innovation, she helps shape focus areas that turn consumer insights into relevant, scalable product solutions.
Lorraine Moran is a registered dietitian with deep clinical, medical nutrition and food industry expertise, recognised for advancing evidence‑based nutrition. She also holds leadership and governance roles across national and European dietetic and regulatory bodies, contributing to professional standards and quality frameworks. In her role as Senior Nutrition Manager at Tirlán, she guides the application of evidence‑based nutrition to product innovation, research and public health initiatives. Lorraine is committed to improve health outcomes and supports the translation of robust science into real‑world impact.
Jonathan Kornstein is Vice President of Rare Disease and Pediatrics at Caidya, where he leads teams delivering clinical trial services tailored to the unique challenges of rare disease and pediatric development. In his role, he oversees operational, clinical, and medical specialists to design and execute patient-centric studies, and provides strategic guidance to clinical management, commercial development, and business development functions.
He brings approximately three decades of experience in the pharmaceutical and clinical research organization industry. He has guided clinical strategies that balance operational rigor with patient needs, and he leads discussions and thought leadership on rare disease trial execution and patient-centric research approaches.
He holds a bachelor’s degree in biology from Hamilton College in Clinton, New York, and is based in Chapel Hill, North Carolina.
Braden Adam is a software engineer and entrepreneur with a passion for public health, systems thinking, and mission-driven innovation. His experience includes strategic advisory work at Deloitte and over six years of active investment analysis, sharpening his ability to assess risk, navigate uncertainty, and design solutions built for long-term impact. Currently, he is applying this mindset to one of the most tightly regulated and stagnant industries in the U.S., helping lead the introduction of a next-generation nicotine alternative. By assembling a diverse team of regulatory, scientific, and strategic experts, he is working to deliver a product that not only meets the highest standards of compliance and user experience, but also redefines harm reduction for both people and the planet.